NewTom BIOLASE VG3 Panoramic Oral X-Ray System Receives FDA Clearance

NewTom BIOLASE VG3 Panoramic Oral X-Ray System Receives FDA Clearance 
VG3 Expected to Be Available for Delivery in June 2013 
IRVINE, CA -- (Marketwired) -- 05/16/13 --  BIOLASE, Inc. (NASDAQ:
BIOL), the world's leading manufacturer and distributor of dental
lasers, announced today that the U.S. Food and Drug Administration
(the "FDA") has cleared the NewTom(TM) BIOLASE VG3 ("VG3") digital
panoramic, cephalometric, and tomographic extra-oral X-ray system
which BIOLASE(R) will market and distribute in the U.S. for $50,000
to $120,000. BIOLASE is the exclusive distributor of NewTom digital
imaging products for the dental market in the U.S. and Canada. 
The VG3 is a significant complement to the ultra-high performance
full field of view ("FOV") provided by the NewTom VGi, which is
currently distributed by BIOLASE. The new VG3 is a truly modular
hybrid 2D/3D system that can start as a digital 2D panoramic X-ray
system, which replaces traditional film-based panoramic units, that
can be upgraded at any time to add either a cephalometric sensor and
software, necessary for orthodontics and diagnosing head, jaw, and
facial pain, and/or 3D cone-beam-computed-tomography ("CBCT") with an
11" x 8" FOV, used for implants, endodontics, gum disease, sinus
problems, and oral and maxillofacial surgery. 
Federico Pignatelli, Chairman and Chief Executive Officer, commented,
"We are very pleased that the NewTom BIOLASE VG3 has received FDA
clearance in the U.S. The VG3 fills a significant need for doctors
who want to replace their older, film-based panoramic units with a
competitively priced, modern digital 2D unit that offers flexibility
to add 3D capabilities as they expand the range of endodontic and
periodontic procedures they perform. Digital panoramic systems emit a
fraction of the radiation compared to older film-based systems, which
make them much safer for patients and staff. Digital imaging also
plays a very important role in the development of improved treatment
plans, the proper placement of implants, and the early diagnosis of
diseases." 
The VG3 comes equipped with NewTom's NNT 4.0 imaging analysis
software and incorporates NewTom's patented Safebeam(TM) technology
which emits the lowest possible dosage of radiation. Safebeam
technology automatically adjusts the radiation dosage and
continuously monitors systems operations thereby eliminating the
possibility of unnecessary exposures making it the safest available
for patients and staff. 
"The VG3 comes equipped with a removable 2D panoramic sensor that
allows operators to safely remove it for use on the cephalometric
arm," said Bill Brown, Vice President of Sales & Marketing. "Billed
as an ideal solution for practices that require a high-quality device
at a competitive price, the 2D panoramic sensor allows practitioners
to make dynamic orthogonal tomogram examinations with the ability to
upgrade the base panoramic VG3 with a cephalometric sensor or
software and a digital 3D CBCT at any time." 
About BIOLASE, Inc.
 BIOLASE, Inc. is a biomedical company that
develops, manufactures, and markets lasers in dentistry and medicine
and also markets and distributes high-end 2D and 3D digital imaging
equipment and CAD/CAM intraoral scanners; products that are focused
on technologies that advance the practice of dentistry and medicine.
The Company's laser products incorporate over 350 patented and
patent-pending technologies designed to provide biologically
clinically superior performance with less pain and faster recovery
times. Its imaging products provide cutting-edge technology at
competitive prices to deliver the best results for dentists and
patients. BIOLASE's principal products are dental laser systems that
perform a broad range of dental procedures, including cosmetic and
complex surgical applications, and a full line of dental imaging
equipment. BIOLASE has sold more than 22,500 lasers.  
Other products under development address ophthalmology and other
medical and consumer markets. 
For updates and information on WaterLase(R) and laser dentistry, find
BIOLASE online at www.biolase.com, Facebook at
www.facebook.com/biolaseinc, Twitter at www.twitter.com/biolaseinc,
Pinterest at www.pinterest.com/biolase, LinkedIn at
www.linkedin.com/company/biolase, Instagram at
www.instagram.com/biolaseinc and YouTube at
www.youtube.com/biolasevideos.  
BIOLASE(R) and WaterLase(R) are registered trademarks or trademarks
of BIOLASE, Inc. 
NewTom(TM) is a trademark of Cefla Dental Group. 
For further information, please contact: 
Michael Porter 
Porter, LeVay & Rose, Inc. 
212-564-4700 
 
 
Press spacebar to pause and continue. Press esc to stop.